ADAMTS13

Takeda Wins First FDA Approval for Ultra-Rare Blood Clotting Disease
BioSpace
Fri, 11/10/23 - 10:12 am
Takeda
FDA
ADAMTS13
Adzynma
cogenital thrombocytopenic purpura